Revamped Navarro adds convenience
MIAMI — Navarro Discount Pharmacy recently celebrated the opening of its 30th store in Homestead, Fla., in the Homestead Pavilion Shopping Center. The store further differentiates the retailer from its competition and caters to the Hispanic market with its mix of ethnic products, such as chili peppers, piñatas and Jumex nectars.
For added convenience and improved customer service, the pharmacy department has been moved to the front of the new 11,280-sq.-ft. store. The store layout features new colors and enhanced signage in English and Spanish, wider aisles, a larger fragrance section with added light boxes, and more products in the refrigerated food and dairy section. Services for customers include a pediatric window for busy parents, compounding pharmacy services, a free Diabetes Club for adults and children, and free prescription delivery for all customers.
To see the photos, click here.
Study: Children at greater risk of ADHD if mother has gestational diabetes, low socioeconomic status
NEW YORK — Mothers that have low socioeconomic status and develop gestational diabetes during pregnancy are more likely to bear children that are diagnosed with attention deficit hyperactivity disorder, according to a new study published in the Archives of Pediatrics & Adolescent Medicine.
Researchers led by Yoko Nomura of CUNY Queens College in Flushing, N.Y., compared 212 offspring (ages 3 and 4 years) of mothers with and without GDM in an economically diverse sample. What they found was that exposure to maternal GDM was associated with a two-fold increased risk for ADHD at 6 years of age, compared with those not exposed. The same rang true for children exposed to low SES — exposure to the factor was associated with a two-fold increased risk for ADHD at 6 years of age. Additionally, when the relationship of GDM and SES exposure was examined, the study authors also found that children were 14 times more likely to develop ADHD when exposed to both GDM and low SES.
"This study demonstrates that children of mothers with GDM raised in lower SES households are at far greater risk for developing ADHD and showing signs of suboptimal neurocognitive and behavioral development," the authors conclude. "Since ADHD is a disorder with high heritability, efforts to prevent exposure to environmental risks through patient education may help to reduce the nongenetic modifiable risk for ADHD and other developmental problems."
FDA approves new REMS for fentanyl-based painkillers
SILVER SPRING, Md. — The Food and Drug Administration is streamlining the enrollment process for risk evaluation and mitigation strategies for a class of painkillers, the agency said Tuesday.
The FDA announced the approval of a single REMS for transmucosal immediate-release fentanyl, or TIRF, drugs. The new system, which takes effect in March, will allow prescribers and pharmacies to enroll into one system instead of individual systems for each product. TIRF drugs include ProStrakan’s Abstral, Cephalon’s Fentora and Actiq, Archimedes Pharma’s Lazanda and Meda Pharmaceuticals’ Onsolis.
"This TIRF REMS will ensure safe use and access to these drugs for patients who need them," FDA Center for Drug Evaluation and Research director Janet Woodcock said. "We have worked with the sponsors of both the innovator and generic drugs to develop this single, shared system that will streamline the process and decrease the burden of the REMS on the healthcare system."